It was found that 75% of the CRC tumors with KLK6 overexpression carried APC mutations and 69% had K-RAS mutations, which indicates that KLK6 contributes to colorectal tumorigenesis downstream of the major colon tumorigenesis pathways [18,27]. This evidence concerns the gene KRAS and colorectal carcinoma.